Sign In

John Yianni

Founder, Investor & Company Builder with a Focus on Cardiovascular Devices & Stroke

John Yianni, CEO of CryoTherapeutics SA

John Yianni is the founder and CEO of CryoTherapeutics SA, a medical device company focused on developing cryotherapy systems for the treatment of coronary plaque to prevent heart attacks.1235 He has a PhD in Biophysics and is an experienced entrepreneur, having founded and served on the boards of several successful medical device companies including Biocompatibles, Thermocore, and Reverse Medical (acquired by Medtronic).2

CryoTherapeutics' technology uses an intravascular catheter to deliver sub-zero temperatures to inflamed areas of the coronary artery, with the aim of stabilizing lesions that could otherwise rupture and cause a heart attack.3 The company recently announced promising clinical data and a €10 million Series B extension round to further develop this innovative cryotherapy system.3

Yianni is also a Partner at Earlybird Venture Capital Health Fund, where he invests in and supports European medtech startups with breakthrough innovations.7 His LinkedIn profile is https://www.linkedin.com/in/john-yianni-8132a2/.46

Related Questions

What are John Yianni's key achievements at CryoTherapeutics?
How did John Yianni's background in biophysics influence his career?
What other companies has John Yianni founded or been involved with?
What is the significance of the €10 Million Series B extension round for CryoTherapeutics?
How does CryoTherapeutics' technology work in preventing heart attacks?
John Yianni
John Yianni, photo 1
John Yianni, photo 2
Add to my network

Location

Berlin, Berlin, Germany